Abstract: Apparatuses, systems, and techniques for white balancing an image are presented. In at least one embodiment, a chromaticity-based weighting function is determined based at least on an estimated scene brightness of the image and applied to exclude or minimize the impact of large colored portions or objects within an image when estimating an illuminant color.

Abstract: Apparatuses, systems, and techniques for white balancing an image are presented. In at least one embodiment, a chromaticity-based weighting function is determined based at least on an estimated scene brightness of the image and applied to exclude or minimize the impact of large colored portions or objects within an image when estimating an illuminant color.

Abstract: A method for depositing a coating comprising a polymer and pharmaceutical agent on a substrate, comprising the following steps: discharging at least one pharmaceutical agent in a therapeutically desirable morphology in dry powder form through a first orifice; discharging at least one polymer in dry powder form through a second orifice; depositing the polymer and/or pharmaceutical particles onto said substrate, wherein an electrical potential is maintained between the substrate and the pharmaceutical and/or polymer particles, thereby forming said coating; and sintering said coating under conditions that do not substantially modify the morphology of said pharmaceutical agent.

Abstract: Improved fallback mechanisms for auto white balancing are presented. In at least one embodiment, white balance correction factors produced by a first white balance technique are blended with white balance correction factors produced by a second white balance technique based on a confidence level in the white balance correction factors produced by the first white balance technique.

Abstract: Apparatuses, systems, and techniques for white balancing an image are presented. In at least one embodiment, a chromaticity-based weighting function is determined based at least on an estimated scene brightness of the image and applied to exclude or minimize the impact of large colored portions or objects within an image when estimating an illuminant color.

Abstract: A method for depositing a coating comprising a polymer and pharmaceutical agent on a substrate, comprising the following steps: discharging at least one pharmaceutical agent in a therapeutically desirable morphology in dry powder form through a first orifice; discharging at least one polymer in dry powder form through a second orifice; depositing the polymer and/or pharmaceutical particles onto said substrate, wherein an electrical potential is maintained between the substrate and the pharmaceutical and/or polymer particles, thereby forming said coating; and sintering said coating under conditions that do not substantially modify the morphology of said pharmaceutical agent.

Abstract: Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on the substrate, wherein the coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within the coating and on the substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of the medical device in the body of the subject a portion of the pharmaceutical agent and/or active biological agent is delivered at the intervention site along with at least a portion of the polymer and/or a at least a portion of the pharmaceutical carrying agents.

Abstract: A method for depositing a coating comprising a polymer and at least two pharmaceutical agents on a substrate, comprising the following steps: providing a stent framework; depositing on said stent framework a first layer comprising a first pharmaceutical agent; depositing a second layer comprising a second pharmaceutical agent; Wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents.

Abstract: Provided is a coated implantable medical device, comprising: a substrate; and a coating disposed on the substrate, wherein the coating comprises at least one polymer and at least one pharmaceutical agent in a therapeutically desirable morphology and/or at least one active biological agent and optionally, one or more pharmaceutical carrying agents; wherein substantially all of pharmaceutical agent and/or active biological agent remains within the coating and on the substrate until the implantable device is deployed at an intervention site inside the body of a subject and wherein upon deployment of the medical device in the body of the subject a portion of the pharmaceutical agent and/or active biological agent is delivered at the intervention site along with at least a portion of the polymer and/or a at least a portion of the pharmaceutical carrying agents.

Abstract: A composite fluid transfer conduit is provided. The conduit includes a first end portion, a second end portion and a main body portion between the first and second end portions. At least one of the first and second end portions is an end portion comprising a circumferential groove in a radially outer surface of the fluid transfer conduit, an axial end face, and a transition surface between the axial end face and the circumferential groove. The transition surface is configured such that, for any angle of impact of the end portion with a planar impact surface, a resultant impact force on the end portion is directed away from the circumferential groove.

Abstract: Provided herein is a coated coronary stent, comprising: a. stent framework; b. a plurality of layers deposited on said stent framework to form said coronary stent; wherein at least one of said layers comprises a bioabsorbable polymer and at least one of said layers comprises one or more active agents; wherein at least part of the active agent is in crystalline form.

Abstract: An isolator includes a first fluid-carrying member and a second fluid-carrying member; and a resistive, semi-conductive or non-conductive component located between the first and the second fluid-carrying member. The component conveys fluid flowing from the first fluid-carrying member to the second fluid-carrying member. The isolator further has a reinforcing composite encircling the first fluid-carrying member, the second fluid-carrying member and the component. The reinforcing composite having first fibers extending at an angle of between ?30 degrees and +30 degrees to a longitudinal axis (A-A) of the resistive, semi-conductive or non-conductive component; second fibers interwoven with the first fibers and extending around the first fluid-carrying member, the second fluid-carrying member and the component at an angle of between +60 degrees and +90 degrees and/or between ?60 degrees and ?90 degrees to the longitudinal axis (A-A); and a resin.

Abstract: A method for preparing a laminate coronary stent comprising: providing a stent framework; and depositing a plurality of layers on said stent framework to form said laminate coronary stent; wherein at least one of said layers comprises a bioabsorbable polymer.

Abstract: Stent delivery systems having improved deliverability comprising an elongate member having an inflation lumen and a guidewire lumen therein; a balloon having an interior that is in fluid communication with the inflation lumen; and a stent comprising a coating mounted on the balloon. Methods for making stent delivery systems having improved deliverability. Methods for delivering two stent delivery systems concurrently through a guiding catheter, each stent delivery system comprising elongate member having an inflation lumen and a guidewire lumen therein, a balloon having an interior that is in fluid communication with the inflation lumen, and a stent comprising a coating mounted on the balloon. Stent coatings may comprise a pharmaceutical agent at least a portion of which is in crystalline form.

Abstract: An electrical isolator includes comprising: a first fluid-carrying member a second fluid-carrying member spaced apart from the first fluid-carrying member to form a gap; a resistive, semi-conductive or non-conductive component extending across the gap and bonded to the first and second fluid-carrying members so as to provide a fluid tight seal between the first fluid-carrying member and the resistive, semi-conductive or non-conductive component and between the second fluid-carrying member and the resistive, semi-conductive or non-conductive component. The isolator also includes a reinforcing composite encircling the first fluid-carrying member, the second fluid-carrying member and the resistive, semi-conductive or non-conductive component.

Abstract: A computer system receives data identifying data fields used by sources of data and infrastructure information. The computer system maintains a storage state database to track information about the data fields. The computer system provides a graphical user interface through which a user can create, view, modify, and delete data defining classes and rules associated with classes. The computer system applies the rules to classify the data fields. The computer system provides a graphical user interface through which the classification of the data fields can be visualized in the context of infrastructure information for the sources of data.

Abstract: A method for depositing a coating comprising a polymer and at least two pharmaceutical agents on a substrate, comprising the following steps: providing a stent framework; depositing on said stent framework a first layer comprising a first pharmaceutical agent; depositing a second layer comprising a second pharmaceutical agent; Wherein said first and second pharmaceutical agents are selected from two different classes of pharmaceutical agents.

Abstract: A bioabsorbable biomedical implant is disclosed. The implant includes a tubular scaffold comprising a plurality of interconnected polymer struts. The interconnected polymer struts defines a plurality of deformable cells. The polymer struts have an average thickness of no more than 120 ?m. Methods for making the bioabsorbable biomedical implant, including the methods for making the polymer materials for the tubular scaffold, are also disclosed.

Abstract: A method for depositing a coating comprising a polymer and pharmaceutical agent on a substrate, comprising the following steps: discharging at least one pharmaceutical agent in a therapeutically desirable morphology in dry powder form through a first orifice; discharging at least one polymer in dry powder form through a second orifice; depositing the polymer and/or pharmaceutical particles onto said substrate, wherein an electrical potential is maintained between the substrate and the pharmaceutical and/or polymer particles, thereby forming said coating; and sintering said coating under conditions that do not substantially modify the morphology of said pharmaceutical agent.